Picture of Newbury Pharmaceuticals AB logo

NEWBRY — Newbury Pharmaceuticals AB News Story

0.000.00%
se flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap

Brief: Newbury Pharmaceuticals Q1 Net Revenue SEK 11,185

Jan 10 (Reuters) - Newbury Pharmaceuticals AB
 NEWBRY.ST :
    * SEPTEMBER 2023 - NOVEMBER 2023 NET REVENUE WAS 11 185
(258) TKR.
    * SEPTEMBER 2023 - NOVEMBER 2023 EBITDA WAS -2 734 (-5 442)
TKR.

Source text for Eikon:  ID:nMFN5QXMGQ 
Further company coverage:  NEWBRY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Newbury Pharmaceuticals AB

See all news